Furthermore, we assessed the expression level of TCAB1 in the NPC specimens, revealing TCAB1 overexpression in 85.1% of EBV-positive NPC biopsies (40 of 47 samples, Fig. 1E,F). Here, WRAP53 is linked to nasopharyngeal carcinoma.